Author

C. E. Hioe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

C. Upadhyay· 3 shared B. K. Chen· 2 shared N. Satija· 2 shared R. A. Alvarez· 2 shared R. Feyznezhad· 2 shared S. Zolla-Pazner· 2 shared A. F. Tang· 1 shared A. Finzi· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

C. Upadhyay

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice

C. E. Hioe, G. Li, X. Liu, O. Tsahouridis, X. He, M. Funaki, J. Klingler, A. F. Tang, R. Feyznezhad, D. W. Heindel, X.-H. Wang, D. A. Spencer, G. Hu, N. Satija, J. Prevost, , L. Su

This study shows that non-neutralizing antibodies targeting HIV-1 envelope regions reduce mucosal infection and virus burden in humanized mice through Fc-mediated effector functions.

bioRxiv · May 24, 2021Immunology

Signal Peptide of HIV-1 Envelope Functions to Modulate Glycosylation Impacting Exposure of V1V2 Epitopes

C. Upadhyay, R. Feyznezhad, L. Cao, K.-W. Chan, K. Liu, W. Yang, H. Zhang, J. Yolitz, J. Arthos, A. Nadas, X.-P. Kong, S. Zolla-Pazner, C. E. Hioe

This study shows that HIV-1 signal peptide diversity affects Env glycosylation and antibody recognition of V1V2 epitopes.

PLOS Pathogens · Dec 28, 2020Peer-reviewedMicrobiology

P2X1 selective antagonists block HIV-1 infection through inhibition of envelope conformation-dependent fusion

A. Y. Soare, H. S. Malik, N. Durham, T. L. Freeman, R. A. Alvarez, F. Patel, N. Satija, C. Upadhyay, C. E. Hioe, B. K. Chen, T. H. Swartz

This paper shows P2X1 antagonists block HIV-1 infection by inhibiting envelope conformation-dependent fusion across multiple viral clades.

bioRxiv · Sep 26, 2019Microbiology